Improvement of risk assessment in cutaneous melanoma (CM) by a prognostic 31-gene expression profile (31-GEP) test over AJCC-based staging alone. (2018). SKIN The Journal of Cutaneous Medicine, 2, S70. https://doi.org/10.25251/skin.2.supp.70